Sang Phil
Sang Phil Hong, Suwon-Si KR
Patent application number | Description | Published |
---|---|---|
20150181333 | METHOD OF REDUCING NOISE IN AUDIO OUTPUT ENVIRONMENT AND ELECTRONIC DEVICE SUPPORTING THE SAME - A method of reducing noise is provided. The method includes determining whether an audio output of the audio source has interference based on a sampling frequency and an operating frequency of at least one device element e, and maintaining or changing the operating frequency of the at least one device element depending on whether interference is determined. | 06-25-2015 |
Sang Phil Hong, Gyeonggi-Do KR
Patent application number | Description | Published |
---|---|---|
20150200638 | AUDIO OUTPUT CONTROL METHOD AND ELECTRONIC DEVICE SUPPORTING THE SAME - Disclosed is an audio output control method and an electronic device supporting the same. The audio output control method includes determining an output of an audio processing unit decoding an audio source signal, and controlling generating of a reference signal to be supplied to an audio output unit in response to an output of the audio processing unit. | 07-16-2015 |
Sang Phil Lee, Youngin-Shi CN
Patent application number | Description | Published |
---|---|---|
20130178072 | IN-SITU CHAMBER CLEANING FOR AN RTP CHAMBER - A method of cleaning a chamber used for annealing doped wafer substrates. In one embodiment the method provides removing dopants deposited in an annealing chamber after an annealing process of a doped substrate by flowing one or more volatilizing gases into the annealing chamber, applying heat to volatilize the deposited dopants in the annealing chamber, and exhausting the chamber to remove volatilized dopants from the annealing chamber. | 07-11-2013 |
Sang Phil Lee, Suwon KR
Patent application number | Description | Published |
---|---|---|
20140111790 | PRETREATMENT METHOD AND APPARATUS - There is provided a method for performing a pretreatment on an unknown sample including: preparing a plurality of different types of first solutions; adding an unknown sample to the plurality of first solutions and determining whether or not the unknown sample is dissolved; selecting one among the plurality of first solutions in which the unknown sample is dissolved; preparing a plurality of second solution by differentiating concentrations of the selected solution; adding an unknown sample to the second solution and determining whether or not the unknown sample is dissolved; selecting a solution having the lowest concentration in which the unknown sample can be dissolved from among the second solutions; and dissolving the unknown sample by using the solution having the lowest concentration. | 04-24-2014 |
Sang Phil Lim, Seoul KR
Patent application number | Description | Published |
---|---|---|
20140325126 | DATA STORAGE DEVICE PERFORMING ATOMIC WRITE AND RELATED METHOD OF OPERATION - A method of operating a data storage device comprises allocating a plurality of data blocks among received data to a plurality of intellectual property (IP) cores, performing an atomic write independently for of the IP cores, wherein the atomic write for each of the IP cores writes corresponding allocated data blocks to a corresponding memory region of the data storage device, and generating an independent identifier indicating completion of the atomic write for each of the IP cores. | 10-30-2014 |
Sang Phil Yoon, Gyeonggi-Do KR
Patent application number | Description | Published |
---|---|---|
20150290322 | SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF ANIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME - Disclosed is a sustained-release lipid pre-concentrate, comprising: a) at least one liquid crystal former; b) at least one phospholipid; c) at least one liquid crystal hardener; and d) at least one bi- or multivalent metal salt, wherein the sustained-release pre-concentrate exists as a lipid liquid phase in the absence of aqueous fluid and forms into a liquid crystal upon exposure to aqueous fluid. The sustained-release lipid pre-concentrate is configured to enhance the sustained release of anionic pharmacologically active substances through ionic interaction between the bi- or multivalent metal salt and the anionic pharmacologically active substances. | 10-15-2015 |